Knowledge Hub
Country: India - Tag: OPV -
This analysis describes an innovative and successful approach to risk identification and mitigation in relation to the switch from trivalent to bivalent oral polio vaccine (OPV) in the 11 countries...
The Immunization Systems Management Group (IMG) was established to coordinate and oversee objective 2 of the Polio Eradication and Endgame Strategic Plan 2013–2018, namely, (1) introduction of ≥1...
Strong progress continues to be made since the Health Assembly called for the worldwide eradication of poliomyelitis in 1988.1 At the time, poliomyelitis was endemic in more than 125 countries around...
During 2 September–4 October 2016, 4 sewage samples collected in Hyderabad in Telangana state between 3 August and 19 September 2016 and 1 sewage sample collected in Ahmedabad in Gujarat state on...
Evidence generated through research studies has guided programmatic actions and fine-tuned strategies for the Global Polio Eradication Initiative (GPEI). However, many gaps still persist in the...
Global Polio Eradication and Endgame Strategic Plan 2013-18 calls for the ultimate withdrawal of oral polio vaccines (OPV) from all immunization programs across the world. The phased globally...
In March 2014, India, the country with historically the highest burden of polio, was declared polio free, with no reported cases since January 2011. We estimate the health and economic benefits of...
Intestinal immunity induced by oral poliovirus vaccine (OPV) is imperfect and wanes with time, permitting transmission of infection by immunised children. Inactivated poliovirus vaccine (IPV) does...
The continued presence of polio in northern India poses challenges to the interruption of wild poliovirus transmission and the management of poliovirus risks in the post-eradication era. We aimed to...
Polio eradication needs a new routine immunisation schedule—three or four doses of bivalent type 1 and type 3 oral poliovirus vaccine (bOPV) and one dose of inactivated poliovirus vaccine (IPV),...
Newborn Vaccination is identified as a critical parameter for evaluating the overall performance of immunization programs with guidelines clearly advocating for administration of BCG, OPV zero dose...
This study assesses the immunogenicity of a novel bivalent types 1 and 3 oral poliovirus vaccine (bOPV).
This report, prepared by the Secretariat for the Decade of Vaccines Global Vaccine Action Plan, serves as the basis for the independent review. As was the case in 2013 and 2014, this report reviews...